RT Journal Article
SR Electronic
T1 Neuroimaging Insights into Subjective Cognitive Decline: Differential Sensitivity of Cognitive Change Index and Everyday Cognition Scale
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.10.24308700
DO 10.1101/2024.06.10.24308700
A1 Morrison, Cassandra
A1 Anderson, John A. E.
A1 Dadar, Mahsa
A1 the Alzheimer’s Disease Neuroimaging Initiative
YR 2024
UL http://medrxiv.org/content/early/2024/06/11/2024.06.10.24308700.abstract
AB Introduction Cognitively healthy older adults may experience self-perceived memory and cognitive deficits, known as subjective cognitive decline (SCD), increasing their risk for dementia- related brain and cognitive changes. This study investigated if questions from the Cognitive Change Index (CCI) and Everyday Cognition Scale (ECog) show similar associations with dementia-related changes.Methods Cognitively healthy older adults (n=332) from the Alzheimer’s Disease Neuroimaging Initiative were included. Partial-least-squares observed the latent variables (LVs) that maximize the relationship between the two questionnaires.Results Two LVs (p’s<0.001) explained 85.89% and 8.30% of the cross-block covariance. In the first LV, several CCI questions correlated with older age and frontal, parietal, and temporal WMHs, lower hippocampal and entorhinal cortex volume, and larger ventricles. The second LV showed younger individuals with higher SCD scores on three CCI questions correlated with temporal and parietal WMHs and entorhinal cortex volumes.Conclusion More questions from the CCI are associated with neuroimaging markers, unlike the ECog questions. These questionnaires may thus be measuring different neural decline patterns and may be sensitive to different etiologies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCM supported by the Canadian Institutes of Health Research (CIHR), JAEA is supported by CRC II (CRC-2020-00174), NSERC-DG (DGECR-2022-00309), MD is supported by the Healthy Brains for Healthy Lives (HBHL), Alzheimer Society Research Program (ASRP), Natural Sciences and Engineering Research Council of Canada (NSERC), Fonds de Recherche du Quebec (FRQS), Douglas Research Centre (DRC) and CIHR.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used data that are openly available at teh adni.loni.usc.edu website.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at adni.loni.usc.edu https://adni.loni.usc.edu/